 Janet Snell-Bergeon
Concepts (467)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 158 | 2024 | 3361 | 16.650 |
Why?
| | Coronary Artery Disease | 42 | 2023 | 648 | 8.910 |
Why?
| | Vascular Calcification | 19 | 2023 | 123 | 7.470 |
Why?
| | Diabetic Nephropathies | 25 | 2022 | 289 | 5.650 |
Why?
| | Diabetic Angiopathies | 29 | 2020 | 261 | 5.490 |
Why?
| | Insulin Resistance | 26 | 2024 | 1184 | 4.410 |
Why?
| | Blood Glucose | 43 | 2024 | 1946 | 3.530 |
Why?
| | Calcinosis | 23 | 2021 | 282 | 3.000 |
Why?
| | Coronary Vessels | 14 | 2023 | 233 | 2.810 |
Why?
| | Albuminuria | 15 | 2022 | 196 | 2.690 |
Why?
| | Blood Glucose Self-Monitoring | 23 | 2024 | 534 | 2.680 |
Why?
| | Adult | 133 | 2024 | 31525 | 2.410 |
Why?
| | Cardiovascular Diseases | 19 | 2024 | 1802 | 2.220 |
Why?
| | Diabetes Complications | 9 | 2019 | 219 | 2.050 |
Why?
| | Risk Factors | 53 | 2023 | 9003 | 1.820 |
Why?
| | Middle Aged | 101 | 2023 | 27627 | 1.770 |
Why?
| | Hypoglycemia | 7 | 2023 | 401 | 1.760 |
Why?
| | Biomarkers | 24 | 2022 | 3590 | 1.710 |
Why?
| | Osteoporotic Fractures | 5 | 2020 | 51 | 1.610 |
Why?
| | Diabetes Mellitus, Type 2 | 16 | 2024 | 2179 | 1.600 |
Why?
| | Diabetic Retinopathy | 5 | 2024 | 160 | 1.570 |
Why?
| | Glomerular Filtration Rate | 22 | 2022 | 684 | 1.560 |
Why?
| | Humans | 181 | 2024 | 119032 | 1.560 |
Why?
| | Female | 137 | 2024 | 61588 | 1.550 |
Why?
| | Disease Progression | 34 | 2023 | 2490 | 1.510 |
Why?
| | Uric Acid | 8 | 2018 | 354 | 1.500 |
Why?
| | Atherosclerosis | 8 | 2022 | 346 | 1.470 |
Why?
| | Male | 127 | 2024 | 57818 | 1.460 |
Why?
| | Young Adult | 54 | 2023 | 10799 | 1.380 |
Why?
| | Insulin | 23 | 2023 | 2170 | 1.340 |
Why?
| | Pregnancy in Diabetics | 2 | 2020 | 88 | 1.320 |
Why?
| | Coronary Disease | 9 | 2015 | 356 | 1.310 |
Why?
| | Glycopeptides | 3 | 2018 | 58 | 1.300 |
Why?
| | Prospective Studies | 27 | 2023 | 6477 | 1.210 |
Why?
| | Hypoglycemic Agents | 16 | 2023 | 1035 | 1.150 |
Why?
| | Cohort Studies | 32 | 2023 | 5117 | 1.110 |
Why?
| | Diet, Mediterranean | 2 | 2023 | 21 | 1.100 |
Why?
| | Calcium | 11 | 2023 | 1171 | 1.080 |
Why?
| | Cross-Sectional Studies | 28 | 2023 | 4552 | 1.070 |
Why?
| | Longitudinal Studies | 12 | 2024 | 2513 | 1.050 |
Why?
| | Case-Control Studies | 27 | 2022 | 3173 | 0.990 |
Why?
| | Insulin Infusion Systems | 7 | 2022 | 306 | 0.970 |
Why?
| | Hyperglycemia | 7 | 2022 | 316 | 0.950 |
Why?
| | Cactaceae | 1 | 2023 | 6 | 0.920 |
Why?
| | Dietary Fiber | 2 | 2023 | 44 | 0.900 |
Why?
| | Inflammation | 5 | 2021 | 2571 | 0.890 |
Why?
| | Follow-Up Studies | 14 | 2023 | 4596 | 0.840 |
Why?
| | Trace Elements | 1 | 2022 | 46 | 0.830 |
Why?
| | Triglycerides | 10 | 2020 | 521 | 0.820 |
Why?
| | Diabetic Cardiomyopathies | 2 | 2019 | 39 | 0.810 |
Why?
| | Obesity | 11 | 2023 | 2751 | 0.800 |
Why?
| | Adiponectin | 6 | 2016 | 226 | 0.800 |
Why?
| | Prediabetic State | 2 | 2023 | 234 | 0.800 |
Why?
| | Cystatin C | 8 | 2015 | 69 | 0.730 |
Why?
| | Bone Density | 7 | 2022 | 449 | 0.720 |
Why?
| | Body Mass Index | 15 | 2021 | 2092 | 0.710 |
Why?
| | Vascular Stiffness | 4 | 2022 | 425 | 0.710 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 2019 | 38 | 0.670 |
Why?
| | Proteomics | 7 | 2022 | 876 | 0.670 |
Why?
| | Uromodulin | 1 | 2018 | 28 | 0.670 |
Why?
| | Apolipoproteins B | 2 | 2015 | 44 | 0.660 |
Why?
| | Cholesterol, HDL | 6 | 2022 | 199 | 0.650 |
Why?
| | Islets of Langerhans | 2 | 2022 | 739 | 0.640 |
Why?
| | Cancellous Bone | 1 | 2017 | 21 | 0.630 |
Why?
| | Pericardium | 2 | 2017 | 50 | 0.630 |
Why?
| | Diet | 3 | 2023 | 1155 | 0.620 |
Why?
| | Kidney | 6 | 2021 | 1357 | 0.610 |
Why?
| | Body Fat Distribution | 1 | 2017 | 45 | 0.600 |
Why?
| | Feeding Behavior | 2 | 2021 | 601 | 0.600 |
Why?
| | Metabolic Syndrome | 1 | 2021 | 394 | 0.600 |
Why?
| | Kidney Function Tests | 3 | 2020 | 164 | 0.590 |
Why?
| | Fear | 1 | 2019 | 307 | 0.590 |
Why?
| | Adolescent | 34 | 2023 | 18483 | 0.580 |
Why?
| | Subcutaneous Fat | 1 | 2017 | 82 | 0.580 |
Why?
| | Adiposity | 6 | 2023 | 516 | 0.580 |
Why?
| | Logistic Models | 12 | 2015 | 1901 | 0.580 |
Why?
| | Kidney Diseases | 2 | 2012 | 442 | 0.570 |
Why?
| | Menopause | 1 | 2019 | 266 | 0.570 |
Why?
| | Femur Neck | 4 | 2022 | 65 | 0.570 |
Why?
| | Exercise | 4 | 2023 | 1657 | 0.560 |
Why?
| | Tomography, X-Ray Computed | 14 | 2019 | 2436 | 0.560 |
Why?
| | Glucagon-Like Peptide 1 | 3 | 2022 | 103 | 0.550 |
Why?
| | Perception | 1 | 2018 | 314 | 0.540 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 2 | 2013 | 44 | 0.530 |
Why?
| | Energy Intake | 4 | 2023 | 448 | 0.530 |
Why?
| | Pyrazines | 2 | 2013 | 72 | 0.530 |
Why?
| | Autoimmunity | 3 | 2022 | 831 | 0.520 |
Why?
| | Brachial Artery | 1 | 2016 | 181 | 0.500 |
Why?
| | Triazoles | 2 | 2013 | 134 | 0.500 |
Why?
| | Dietary Fats | 3 | 2021 | 325 | 0.490 |
Why?
| | Self Report | 1 | 2018 | 699 | 0.490 |
Why?
| | Renal Insufficiency | 1 | 2016 | 150 | 0.490 |
Why?
| | Renal Insufficiency, Chronic | 5 | 2021 | 590 | 0.480 |
Why?
| | Fractures, Bone | 1 | 2019 | 380 | 0.480 |
Why?
| | Fibrinogen | 4 | 2023 | 161 | 0.480 |
Why?
| | Pilot Projects | 10 | 2021 | 1420 | 0.480 |
Why?
| | Metformin | 1 | 2017 | 295 | 0.470 |
Why?
| | Menarche | 2 | 2011 | 51 | 0.470 |
Why?
| | Up-Regulation | 2 | 2016 | 872 | 0.470 |
Why?
| | Patient Care Planning | 1 | 2014 | 143 | 0.460 |
Why?
| | Postprandial Period | 2 | 2013 | 96 | 0.450 |
Why?
| | Prognosis | 8 | 2018 | 3443 | 0.440 |
Why?
| | Glucagon | 1 | 2013 | 98 | 0.440 |
Why?
| | Models, Theoretical | 2 | 2015 | 556 | 0.420 |
Why?
| | Predictive Value of Tests | 12 | 2020 | 1868 | 0.420 |
Why?
| | Pancreas, Artificial | 2 | 2023 | 71 | 0.410 |
Why?
| | Ketosis | 2 | 2022 | 13 | 0.410 |
Why?
| | Lipids | 5 | 2022 | 608 | 0.400 |
Why?
| | Patient Satisfaction | 1 | 2015 | 610 | 0.400 |
Why?
| | Aged | 19 | 2021 | 19661 | 0.400 |
Why?
| | Cholesterol | 6 | 2014 | 375 | 0.390 |
Why?
| | Incidence | 6 | 2021 | 2424 | 0.390 |
Why?
| | Evidence-Based Medicine | 2 | 2012 | 693 | 0.390 |
Why?
| | Child | 23 | 2022 | 19137 | 0.390 |
Why?
| | Age Factors | 11 | 2020 | 2995 | 0.380 |
Why?
| | Colorado | 9 | 2016 | 4196 | 0.360 |
Why?
| | Proteinuria | 2 | 2010 | 99 | 0.350 |
Why?
| | Periodontal Diseases | 2 | 2023 | 58 | 0.350 |
Why?
| | Adipose Tissue | 4 | 2018 | 606 | 0.350 |
Why?
| | Prevalence | 11 | 2023 | 2326 | 0.350 |
Why?
| | Diabetic Ketoacidosis | 2 | 2022 | 168 | 0.350 |
Why?
| | Haptoglobins | 3 | 2015 | 49 | 0.350 |
Why?
| | Self-Management | 2 | 2023 | 136 | 0.340 |
Why?
| | Creatinine | 9 | 2022 | 491 | 0.340 |
Why?
| | Diet, Ketogenic | 1 | 2009 | 32 | 0.340 |
Why?
| | Aging | 1 | 2019 | 1677 | 0.340 |
Why?
| | Retrospective Studies | 9 | 2024 | 12990 | 0.340 |
Why?
| | Sex Factors | 8 | 2020 | 1781 | 0.320 |
Why?
| | Reproductive History | 1 | 2008 | 12 | 0.320 |
Why?
| | Collagen | 1 | 2010 | 433 | 0.320 |
Why?
| | Glucose Clamp Technique | 8 | 2018 | 195 | 0.320 |
Why?
| | Time Factors | 8 | 2018 | 6414 | 0.320 |
Why?
| | Blood Pressure | 9 | 2017 | 1664 | 0.320 |
Why?
| | Vitamins | 2 | 2022 | 159 | 0.310 |
Why?
| | Muscle, Skeletal | 4 | 2020 | 1523 | 0.310 |
Why?
| | Genome-Wide Association Study | 3 | 2019 | 1323 | 0.310 |
Why?
| | Absorptiometry, Photon | 5 | 2022 | 229 | 0.310 |
Why?
| | Lumbar Vertebrae | 3 | 2020 | 215 | 0.310 |
Why?
| | Osteoporosis | 3 | 2020 | 229 | 0.300 |
Why?
| | C-Reactive Protein | 3 | 2023 | 364 | 0.300 |
Why?
| | Lipoproteins, HDL | 2 | 2019 | 82 | 0.300 |
Why?
| | Anthropometry | 3 | 2017 | 194 | 0.300 |
Why?
| | Surveys and Questionnaires | 7 | 2021 | 4709 | 0.290 |
Why?
| | Heart Rate | 1 | 2010 | 729 | 0.290 |
Why?
| | Contraception | 1 | 2008 | 118 | 0.290 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2019 | 211 | 0.270 |
Why?
| | Early Diagnosis | 2 | 2017 | 230 | 0.270 |
Why?
| | Multivariate Analysis | 5 | 2015 | 1474 | 0.260 |
Why?
| | Abdominal Wall | 1 | 2004 | 27 | 0.250 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2016 | 21 | 0.240 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2023 | 82 | 0.230 |
Why?
| | Pregnancy | 6 | 2021 | 5694 | 0.230 |
Why?
| | Fast Foods | 1 | 2023 | 16 | 0.230 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2023 | 32 | 0.230 |
Why?
| | Cholesterol, LDL | 3 | 2015 | 317 | 0.230 |
Why?
| | Food Handling | 1 | 2023 | 48 | 0.230 |
Why?
| | Risk Assessment | 6 | 2020 | 3057 | 0.230 |
Why?
| | Calcium, Dietary | 1 | 2023 | 55 | 0.230 |
Why?
| | Sweetening Agents | 1 | 2023 | 52 | 0.220 |
Why?
| | Periodontitis | 1 | 2023 | 42 | 0.220 |
Why?
| | Plaque, Atherosclerotic | 2 | 2014 | 40 | 0.220 |
Why?
| | Glucose Intolerance | 1 | 2024 | 139 | 0.210 |
Why?
| | Lipoproteins | 2 | 2016 | 163 | 0.210 |
Why?
| | Pulmonary Surfactant-Associated Protein B | 1 | 2022 | 6 | 0.210 |
Why?
| | Manganese | 1 | 2022 | 55 | 0.210 |
Why?
| | Polymorphism, Genetic | 5 | 2011 | 642 | 0.210 |
Why?
| | Benchmarking | 1 | 2023 | 172 | 0.210 |
Why?
| | Insulins | 1 | 2022 | 34 | 0.210 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 150 | 0.200 |
Why?
| | Diglycerides | 2 | 2020 | 56 | 0.200 |
Why?
| | Copper | 1 | 2022 | 102 | 0.200 |
Why?
| | Mass Spectrometry | 4 | 2017 | 681 | 0.200 |
Why?
| | Peptides | 3 | 2017 | 879 | 0.200 |
Why?
| | Inflammasomes | 1 | 2023 | 120 | 0.200 |
Why?
| | Diet Surveys | 1 | 2021 | 85 | 0.200 |
Why?
| | Intra-Abdominal Fat | 3 | 2017 | 98 | 0.200 |
Why?
| | Pregnancy Outcome | 2 | 2021 | 349 | 0.200 |
Why?
| | Automobile Driving | 1 | 2023 | 128 | 0.200 |
Why?
| | Insulin, Long-Acting | 1 | 2021 | 51 | 0.200 |
Why?
| | Beverages | 1 | 2021 | 70 | 0.200 |
Why?
| | Regression Analysis | 7 | 2014 | 984 | 0.190 |
Why?
| | Dyslipidemias | 3 | 2015 | 162 | 0.190 |
Why?
| | Meat | 1 | 2021 | 89 | 0.190 |
Why?
| | Proteome | 2 | 2017 | 353 | 0.190 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 945 | 0.190 |
Why?
| | Genotype | 7 | 2018 | 1882 | 0.190 |
Why?
| | Blindness | 1 | 2020 | 35 | 0.190 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 827 | 0.180 |
Why?
| | Vitamin D Deficiency | 2 | 2013 | 162 | 0.180 |
Why?
| | Fruit | 1 | 2021 | 130 | 0.180 |
Why?
| | Double-Blind Method | 5 | 2022 | 1687 | 0.180 |
Why?
| | Glomerular Basement Membrane | 1 | 2019 | 7 | 0.180 |
Why?
| | Foam Cells | 1 | 2019 | 15 | 0.180 |
Why?
| | Collagen Type IV | 1 | 2019 | 22 | 0.180 |
Why?
| | Reproducibility of Results | 4 | 2018 | 2874 | 0.180 |
Why?
| | Hip Fractures | 1 | 2020 | 79 | 0.170 |
Why?
| | Bone Development | 1 | 2019 | 53 | 0.170 |
Why?
| | Severity of Illness Index | 3 | 2016 | 2674 | 0.170 |
Why?
| | Premenopause | 1 | 2019 | 108 | 0.170 |
Why?
| | Radius | 1 | 2019 | 33 | 0.170 |
Why?
| | Diet Records | 1 | 2019 | 81 | 0.170 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2021 | 157 | 0.170 |
Why?
| | Waist Circumference | 2 | 2015 | 130 | 0.170 |
Why?
| | Weight Gain | 2 | 2019 | 493 | 0.160 |
Why?
| | Bone Diseases, Metabolic | 1 | 2019 | 60 | 0.160 |
Why?
| | Sex Distribution | 3 | 2010 | 351 | 0.160 |
Why?
| | Antioxidants | 1 | 2022 | 564 | 0.160 |
Why?
| | United States | 6 | 2023 | 12557 | 0.160 |
Why?
| | Sodium Bicarbonate | 1 | 2018 | 45 | 0.160 |
Why?
| | Accelerometry | 1 | 2018 | 72 | 0.160 |
Why?
| | Depressive Disorder, Major | 1 | 2021 | 303 | 0.160 |
Why?
| | Depression | 2 | 2021 | 1137 | 0.160 |
Why?
| | Coronary Angiography | 2 | 2014 | 311 | 0.160 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2018 | 74 | 0.150 |
Why?
| | Obesity, Abdominal | 1 | 2017 | 39 | 0.150 |
Why?
| | Sex Characteristics | 4 | 2018 | 671 | 0.150 |
Why?
| | Linear Models | 4 | 2014 | 827 | 0.150 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2017 | 18 | 0.150 |
Why?
| | Sphingolipids | 1 | 2018 | 62 | 0.150 |
Why?
| | Tibia | 1 | 2019 | 177 | 0.150 |
Why?
| | Hyperlipidemias | 2 | 2011 | 128 | 0.150 |
Why?
| | Self Care | 2 | 2018 | 357 | 0.150 |
Why?
| | Retinal Vessels | 1 | 2017 | 53 | 0.150 |
Why?
| | C-Peptide | 1 | 2018 | 139 | 0.150 |
Why?
| | Cross-Over Studies | 4 | 2022 | 456 | 0.150 |
Why?
| | Random Allocation | 1 | 2018 | 349 | 0.150 |
Why?
| | Albumins | 2 | 2016 | 100 | 0.150 |
Why?
| | Dietary Supplements | 2 | 2018 | 467 | 0.150 |
Why?
| | Sleep Deprivation | 1 | 2019 | 164 | 0.150 |
Why?
| | Autoantigens | 1 | 2019 | 397 | 0.140 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2018 | 177 | 0.140 |
Why?
| | Vascular Capacitance | 1 | 2016 | 4 | 0.140 |
Why?
| | Autoantibodies | 2 | 2022 | 1335 | 0.140 |
Why?
| | Hip Joint | 1 | 2017 | 144 | 0.140 |
Why?
| | Vitreoretinopathy, Proliferative | 1 | 2016 | 12 | 0.140 |
Why?
| | Sitagliptin Phosphate | 2 | 2013 | 30 | 0.140 |
Why?
| | Electrophoresis, Capillary | 2 | 2017 | 22 | 0.130 |
Why?
| | Hypertension | 5 | 2015 | 1203 | 0.130 |
Why?
| | Pulse Wave Analysis | 3 | 2023 | 216 | 0.130 |
Why?
| | Circadian Rhythm | 1 | 2019 | 401 | 0.130 |
Why?
| | Cannabis | 1 | 2022 | 382 | 0.130 |
Why?
| | Software | 1 | 2019 | 613 | 0.130 |
Why?
| | Vitamin E | 1 | 2015 | 116 | 0.130 |
Why?
| | Observational Studies as Topic | 1 | 2015 | 89 | 0.130 |
Why?
| | Apolipoproteins | 1 | 2014 | 40 | 0.130 |
Why?
| | Peptidomimetics | 1 | 2014 | 2 | 0.120 |
Why?
| | Achievement | 1 | 2014 | 58 | 0.120 |
Why?
| | Breakfast | 1 | 2014 | 17 | 0.120 |
Why?
| | Hemodynamics | 1 | 2018 | 1004 | 0.120 |
Why?
| | Liver | 4 | 2015 | 1816 | 0.120 |
Why?
| | Fructose | 1 | 2015 | 204 | 0.120 |
Why?
| | Acute Coronary Syndrome | 1 | 2017 | 257 | 0.120 |
Why?
| | Goals | 1 | 2015 | 167 | 0.120 |
Why?
| | Sleep | 1 | 2019 | 660 | 0.110 |
Why?
| | Motor Activity | 1 | 2018 | 666 | 0.110 |
Why?
| | Risk | 1 | 2016 | 854 | 0.110 |
Why?
| | HLA-DR2 Antigen | 1 | 2012 | 8 | 0.110 |
Why?
| | Chromatography, Liquid | 2 | 2012 | 355 | 0.110 |
Why?
| | Bromocriptine | 2 | 2022 | 28 | 0.110 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2012 | 48 | 0.110 |
Why?
| | Neovascularization, Pathologic | 2 | 2011 | 287 | 0.110 |
Why?
| | Fasting | 1 | 2014 | 264 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 404 | 0.110 |
Why?
| | HLA-DQ beta-Chains | 1 | 2012 | 61 | 0.110 |
Why?
| | Quality of Life | 1 | 2023 | 2369 | 0.110 |
Why?
| | HLA-DRB1 Chains | 1 | 2012 | 97 | 0.110 |
Why?
| | Animals | 9 | 2022 | 33399 | 0.100 |
Why?
| | Models, Statistical | 1 | 2015 | 636 | 0.100 |
Why?
| | Apolipoprotein C-III | 2 | 2023 | 13 | 0.100 |
Why?
| | Early Medical Intervention | 1 | 2012 | 56 | 0.100 |
Why?
| | Puberty, Delayed | 1 | 2011 | 5 | 0.100 |
Why?
| | Menstruation Disturbances | 1 | 2011 | 12 | 0.100 |
Why?
| | Allylamine | 1 | 2011 | 7 | 0.100 |
Why?
| | Mutation | 2 | 2019 | 3457 | 0.100 |
Why?
| | Adipocytes | 1 | 2012 | 199 | 0.100 |
Why?
| | ROC Curve | 3 | 2020 | 473 | 0.100 |
Why?
| | Angiopoietin-1 | 1 | 2010 | 10 | 0.100 |
Why?
| | Angiopoietin-2 | 1 | 2010 | 13 | 0.100 |
Why?
| | Aged, 80 and over | 3 | 2018 | 6562 | 0.100 |
Why?
| | Matrix Metalloproteinases | 1 | 2011 | 90 | 0.100 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2010 | 67 | 0.100 |
Why?
| | Gastrointestinal Diseases | 1 | 2012 | 187 | 0.090 |
Why?
| | Cardiovascular System | 1 | 2012 | 127 | 0.090 |
Why?
| | Observer Variation | 1 | 2011 | 309 | 0.090 |
Why?
| | Pregnant Women | 2 | 2021 | 132 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2015 | 523 | 0.090 |
Why?
| | Vitamin D | 1 | 2013 | 354 | 0.090 |
Why?
| | Patient Education as Topic | 2 | 2005 | 699 | 0.090 |
Why?
| | Models, Biological | 3 | 2015 | 1715 | 0.090 |
Why?
| | Treatment Outcome | 4 | 2020 | 9346 | 0.090 |
Why?
| | Hypolipidemic Agents | 1 | 2010 | 86 | 0.090 |
Why?
| | Glucose Tolerance Test | 2 | 2024 | 368 | 0.090 |
Why?
| | Rats | 3 | 2015 | 5394 | 0.090 |
Why?
| | Sarcolemma | 2 | 2020 | 29 | 0.090 |
Why?
| | Age of Onset | 2 | 2009 | 467 | 0.090 |
Why?
| | Waist-Hip Ratio | 2 | 2009 | 31 | 0.090 |
Why?
| | Anticholesteremic Agents | 1 | 2011 | 131 | 0.090 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2015 | 985 | 0.080 |
Why?
| | Cytosol | 2 | 2020 | 221 | 0.080 |
Why?
| | Puberty | 1 | 2010 | 144 | 0.080 |
Why?
| | Alleles | 3 | 2018 | 832 | 0.080 |
Why?
| | Leptin | 1 | 2010 | 231 | 0.080 |
Why?
| | Infant, Newborn | 3 | 2021 | 5256 | 0.080 |
Why?
| | Radiography | 1 | 2011 | 861 | 0.080 |
Why?
| | Algorithms | 1 | 2015 | 1543 | 0.080 |
Why?
| | Mass Screening | 2 | 2013 | 1052 | 0.080 |
Why?
| | Mice | 7 | 2022 | 15528 | 0.080 |
Why?
| | Angiotensin II Type 2 Receptor Blockers | 1 | 2007 | 8 | 0.080 |
Why?
| | Cystatins | 1 | 2007 | 7 | 0.080 |
Why?
| | Fatty Acids | 1 | 2010 | 407 | 0.080 |
Why?
| | Electrocardiography | 1 | 2010 | 556 | 0.080 |
Why?
| | Clinical Trials as Topic | 1 | 2012 | 968 | 0.080 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2010 | 209 | 0.080 |
Why?
| | Contraceptive Agents, Female | 1 | 2008 | 65 | 0.070 |
Why?
| | Antidepressive Agents | 1 | 2009 | 189 | 0.070 |
Why?
| | Sensitivity and Specificity | 3 | 2022 | 1795 | 0.070 |
Why?
| | Life Style | 1 | 2009 | 431 | 0.070 |
Why?
| | Endoplasmic Reticulum | 2 | 2020 | 241 | 0.070 |
Why?
| | Extracellular Matrix | 1 | 2010 | 446 | 0.070 |
Why?
| | Renin-Angiotensin System | 1 | 2007 | 82 | 0.070 |
Why?
| | Apolipoproteins A | 1 | 2006 | 18 | 0.070 |
Why?
| | Registries | 3 | 2020 | 1810 | 0.070 |
Why?
| | Gene Frequency | 3 | 2018 | 513 | 0.070 |
Why?
| | Reference Values | 4 | 2010 | 775 | 0.070 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2021 | 167 | 0.070 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 195 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2010 | 692 | 0.070 |
Why?
| | Receptors, Interleukin-2 | 1 | 2005 | 65 | 0.070 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2018 | 536 | 0.070 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2010 | 387 | 0.070 |
Why?
| | Antihypertensive Agents | 2 | 2007 | 438 | 0.060 |
Why?
| | Radiography, Abdominal | 1 | 2004 | 32 | 0.060 |
Why?
| | Glucose | 2 | 2021 | 954 | 0.060 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2012 | 1185 | 0.060 |
Why?
| | Alcohol Drinking | 1 | 2009 | 652 | 0.060 |
Why?
| | Stroke | 1 | 2012 | 1046 | 0.060 |
Why?
| | Infant | 2 | 2017 | 8295 | 0.060 |
Why?
| | Odds Ratio | 3 | 2011 | 996 | 0.060 |
Why?
| | Mice, Inbred NOD | 2 | 2015 | 574 | 0.060 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2023 | 68 | 0.060 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 369 | 0.060 |
Why?
| | Cathepsin D | 1 | 2022 | 13 | 0.050 |
Why?
| | Exercise Tolerance | 1 | 2024 | 233 | 0.050 |
Why?
| | Non-Randomized Controlled Trials as Topic | 1 | 2021 | 20 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2015 | 2220 | 0.050 |
Why?
| | Smoking | 1 | 2009 | 1487 | 0.050 |
Why?
| | Ketone Bodies | 1 | 2021 | 17 | 0.050 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2021 | 15 | 0.050 |
Why?
| | Lipase | 1 | 2002 | 70 | 0.050 |
Why?
| | Glycerol | 2 | 2012 | 88 | 0.050 |
Why?
| | Ketones | 1 | 2021 | 45 | 0.050 |
Why?
| | Breath Tests | 1 | 2021 | 90 | 0.050 |
Why?
| | Technology | 1 | 2021 | 83 | 0.050 |
Why?
| | Behavior Therapy | 1 | 2023 | 237 | 0.050 |
Why?
| | Diabetes, Gestational | 1 | 2005 | 284 | 0.050 |
Why?
| | Insulin Glargine | 1 | 2020 | 73 | 0.050 |
Why?
| | Oligodeoxyribonucleotides, Antisense | 1 | 2019 | 8 | 0.040 |
Why?
| | Phospholipids | 1 | 2021 | 208 | 0.040 |
Why?
| | Mitochondria, Muscle | 1 | 2020 | 97 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2022 | 421 | 0.040 |
Why?
| | Physical Endurance | 1 | 2020 | 231 | 0.040 |
Why?
| | Aryldialkylphosphatase | 1 | 2019 | 20 | 0.040 |
Why?
| | beta 2-Microglobulin | 1 | 2018 | 47 | 0.040 |
Why?
| | Lipocalin-2 | 1 | 2018 | 64 | 0.040 |
Why?
| | Insulin Aspart | 1 | 2018 | 26 | 0.040 |
Why?
| | Microscopy, Polarization | 1 | 2018 | 33 | 0.040 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 1 | 2018 | 36 | 0.040 |
Why?
| | Cytokines | 2 | 2017 | 1900 | 0.040 |
Why?
| | Retinal Artery | 1 | 2017 | 15 | 0.040 |
Why?
| | Postmenopause | 1 | 2020 | 306 | 0.040 |
Why?
| | Retinal Vein | 1 | 2017 | 13 | 0.040 |
Why?
| | Injections | 1 | 2018 | 167 | 0.040 |
Why?
| | Fundus Oculi | 1 | 2017 | 41 | 0.040 |
Why?
| | Osmolar Concentration | 1 | 2018 | 185 | 0.040 |
Why?
| | Canada | 1 | 2018 | 340 | 0.040 |
Why?
| | Pelvic Bones | 1 | 2020 | 127 | 0.040 |
Why?
| | Longevity | 1 | 2018 | 151 | 0.040 |
Why?
| | Health Behavior | 1 | 2023 | 720 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2020 | 580 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2002 | 1158 | 0.040 |
Why?
| | Athletes | 1 | 2020 | 353 | 0.040 |
Why?
| | Vascular Resistance | 1 | 2018 | 356 | 0.040 |
Why?
| | Photography | 1 | 2017 | 93 | 0.040 |
Why?
| | Support Vector Machine | 1 | 2017 | 36 | 0.040 |
Why?
| | Regional Blood Flow | 1 | 2018 | 418 | 0.040 |
Why?
| | Feeding and Eating Disorders | 1 | 2018 | 125 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2018 | 656 | 0.040 |
Why?
| | Blood Banks | 1 | 2016 | 43 | 0.040 |
Why?
| | Organ Size | 1 | 2017 | 460 | 0.040 |
Why?
| | Health Personnel | 1 | 2022 | 588 | 0.040 |
Why?
| | Area Under Curve | 1 | 2017 | 296 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2018 | 2275 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2018 | 306 | 0.030 |
Why?
| | Autophagy-Related Proteins | 1 | 2015 | 46 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2015 | 156 | 0.030 |
Why?
| | Acute Disease | 1 | 2017 | 941 | 0.030 |
Why?
| | Lipoproteins, LDL | 1 | 2015 | 138 | 0.030 |
Why?
| | Kidney Tubules | 1 | 2015 | 128 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2015 | 133 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 372 | 0.030 |
Why?
| | HLA-DQ Antigens | 1 | 2015 | 176 | 0.030 |
Why?
| | Vasodilation | 1 | 2017 | 457 | 0.030 |
Why?
| | Phenotype | 2 | 2013 | 3004 | 0.030 |
Why?
| | Purines | 1 | 2015 | 161 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1079 | 0.030 |
Why?
| | Antigen-Antibody Reactions | 1 | 2013 | 51 | 0.030 |
Why?
| | Insulin-Secreting Cells | 1 | 2018 | 330 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1267 | 0.030 |
Why?
| | Primary Prevention | 1 | 2015 | 185 | 0.030 |
Why?
| | Interleukin-10 | 1 | 2015 | 306 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2015 | 439 | 0.030 |
Why?
| | Cause of Death | 1 | 2015 | 380 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2019 | 2680 | 0.030 |
Why?
| | Mitochondria | 1 | 2018 | 786 | 0.030 |
Why?
| | Abdominal Fat | 1 | 2012 | 48 | 0.030 |
Why?
| | Molecular Weight | 1 | 2012 | 343 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2015 | 737 | 0.030 |
Why?
| | Colesevelam Hydrochloride | 1 | 2011 | 7 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 332 | 0.020 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2015 | 634 | 0.020 |
Why?
| | Vitamin D-Binding Protein | 1 | 2010 | 14 | 0.020 |
Why?
| | Societies, Medical | 1 | 2015 | 703 | 0.020 |
Why?
| | Vascular Diseases | 1 | 2013 | 241 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2073 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1206 | 0.020 |
Why?
| | Receptors, Calcitriol | 1 | 2010 | 56 | 0.020 |
Why?
| | Abdomen | 1 | 2010 | 110 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2873 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 403 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2018 | 2062 | 0.020 |
Why?
| | Nutrition Surveys | 1 | 2011 | 233 | 0.020 |
Why?
| | Biostatistics | 1 | 2009 | 18 | 0.020 |
Why?
| | Cysts | 1 | 2010 | 93 | 0.020 |
Why?
| | Finland | 1 | 2009 | 71 | 0.020 |
Why?
| | Hyperinsulinism | 1 | 2010 | 108 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1384 | 0.020 |
Why?
| | Calibration | 1 | 2009 | 135 | 0.020 |
Why?
| | Proteins | 1 | 2015 | 938 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 525 | 0.020 |
Why?
| | Europe | 1 | 2009 | 356 | 0.020 |
Why?
| | Spleen | 1 | 2010 | 510 | 0.020 |
Why?
| | Personality Inventory | 1 | 2009 | 134 | 0.020 |
Why?
| | Environmental Monitoring | 1 | 2010 | 296 | 0.020 |
Why?
| | Diabetic Neuropathies | 1 | 2009 | 78 | 0.020 |
Why?
| | Health Surveys | 1 | 2009 | 454 | 0.020 |
Why?
| | Angiotensins | 1 | 2007 | 11 | 0.020 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2007 | 22 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2010 | 477 | 0.020 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2007 | 56 | 0.020 |
Why?
| | Patient Compliance | 1 | 2011 | 537 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2013 | 1285 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2010 | 1295 | 0.020 |
Why?
| | Body Composition | 1 | 2010 | 653 | 0.020 |
Why?
| | Ultrasonography | 1 | 2010 | 716 | 0.020 |
Why?
| | Patient Selection | 1 | 2010 | 675 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2011 | 2478 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2015 | 3730 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2006 | 276 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2010 | 727 | 0.020 |
Why?
| | Maternal Age | 1 | 2005 | 122 | 0.020 |
Why?
| | Age Distribution | 1 | 2005 | 362 | 0.020 |
Why?
| | Child, Preschool | 1 | 2017 | 9493 | 0.010 |
Why?
| | Signal Transduction | 1 | 2015 | 4713 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2011 | 4914 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2006 | 1179 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1388 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2010 | 3175 | 0.010 |
Why?
|
|
Snell-Bergeon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|